Large Animal Models of Heart Failure A Critical Link in the Translation of Basic Science to Clinical Practice

被引:240
作者
Dixon, Jennifer A.
Spinale, Francis G.
机构
[1] Med Univ S Carolina, Div Cardiothorac Surg, Charleston, SC 29425 USA
[2] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC USA
关键词
myocardial infarction; myocardial remodeling; overload states; rapid pacing; MESENCHYMAL STEM-CELLS; LEFT-VENTRICULAR FUNCTION; MATRIX-METALLOPROTEINASE INHIBITION; CARDIAC SUPPORT DEVICE; BONE-MARROW-CELLS; MYOCARDIAL-INFARCTION; RECEPTOR BLOCKADE; VOLUME OVERLOAD; INTRAMYOCARDIAL INJECTION; MITRAL REGURGITATION;
D O I
10.1161/CIRCHEARTFAILURE.108.814459
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Congestive heart failure (HF) is a clinical syndrome, with hallmarks of fatigue and dyspnea, that continues to be highly prevalent and morbid. Because of the growing burden of HF as the population ages, the need to develop new pharmacological treatments and therapeutic interventions is of paramount importance. Common pathophysiologic features of HF include changes in left ventricle structure, function, and neurohormonal activation. The recapitulation of the HF phenotype in large animal models can allow for the translation of basic science discoveries into clinical therapies. Models of myocardial infarction/ischemia, ischemic cardiomyopathy, ventricular pressure and volume overload, and pacing-induced dilated cardiomyopathy have been created in dogs, pigs, and sheep for the investigation of HF and potential therapies. Large animal models recapitulating the clinical HF phenotype and translating basic science to clinical applications have successfully traveled the journey from bench to bedside. Undoubtedly, large animal models of HF will continue to play a crucial role in the elucidation of biological pathways involved in HF and the development and refinement of HF therapies. (Circ Heart Fail. 2009;2:262-271.)
引用
收藏
页码:262 / 271
页数:10
相关论文
共 79 条
  • [1] ALTERATIONS OF MYOCARDIAL BLOOD-FLOW ASSOCIATED WITH EXPERIMENTAL CANINE LEFT-VENTRICULAR HYPERTROPHY SECONDARY TO VALVULAR AORTIC-STENOSIS
    ALYONO, D
    ANDERSON, RW
    PARRISH, DG
    DAI, XZ
    BACHE, RJ
    [J]. CIRCULATION RESEARCH, 1986, 58 (01) : 47 - 57
  • [2] Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102
  • [3] Cardiac support device modifies left ventricular geometry and myocardial structure after myocardial infarction
    Blom, AS
    Mukherjee, R
    Pilla, JJ
    Lowry, AS
    Yarbrough, WM
    Mingoia, JT
    Hendrick, JW
    Stroud, RE
    McLean, JE
    Affuso, J
    Gorman, RC
    Gorman, JH
    Acker, MA
    Spinale, FG
    [J]. CIRCULATION, 2005, 112 (09) : 1274 - 1283
  • [4] β-adrenergic receptor blockade in chronic heart failure
    Bristow, MR
    [J]. CIRCULATION, 2000, 101 (05) : 558 - 569
  • [5] Translational research: Crossing the valley of death
    Butler, Declan
    [J]. NATURE, 2008, 453 (7197) : 840 - 842
  • [6] Percutaneous mitral annular reduction provides continued benefit in an ovine model of dilated cardiomyopathy
    Byrne, MJ
    Kaye, DM
    Mathis, M
    Reuter, DG
    Alferness, CA
    Power, JM
    [J]. CIRCULATION, 2004, 110 (19) : 3088 - 3092
  • [7] DYSFUNCTION OF THE BETA-ADRENERGIC AND ALPHA-ADRENERGIC SYSTEMS IN A MODEL OF CONGESTIVE-HEART-FAILURE - THE PACING-OVERDRIVE DOG
    CALDERONE, A
    BOUVIER, M
    LI, K
    JUNEAU, C
    DECHAMPLAIN, J
    ROULEAU, JL
    [J]. CIRCULATION RESEARCH, 1991, 69 (02) : 332 - 343
  • [8] LEFT-VENTRICULAR FUNCTION IN EXPERIMENTAL VOLUME OVERLOAD HYPERTROPHY
    CARABELLO, BA
    NAKANO, K
    CORIN, W
    BIEDERMAN, R
    SPANN, JF
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 256 (04): : H974 - H981
  • [9] Reversal of global apoptosis and regional stress kinase activation by cardiac resynchronization
    Chakir, Khalid
    Daya, Samantapudi K.
    Tunin, Richard S.
    Helm, Robert H.
    Byrne, Melissa J.
    Dimaano, Veronica L.
    Lardo, Albert C.
    Abraham, Theodore P.
    Tomaselli, Gordon F.
    Kass, David A.
    [J]. CIRCULATION, 2008, 117 (11) : 1369 - 1377
  • [10] A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure
    Cohn, JN
    Tognoni, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (23) : 1667 - 1675